ARCA biopharma, Inc.

ARCA biopharma has completed a merger with Oruka Therapeutics and will implement a 1-for-12 reverse stock split. The combined company will operate under the name Oruka Therapeutics and trade on Nasdaq under the ticker 'ORKA'.

Related tickers: ABIO.

ARCA biopharma announced an update to the previously announced final amount of the special cash dividend, which will now equal $1.613 per share, payable on August 28, 2024. The special dividend is in connection with the proposed merger between ARCA and Oruka Therapeutics, which is expected to close on August 29, 2024.

Related tickers: ABIO.